Drug Profile
GPI 5000
Alternative Names: 2-PMPALatest Information Update: 16 Feb 2006
Price :
$50
*
At a glance
- Originator MGI GP
- Class Antiepileptic drugs; Neuroprotectants; Small molecules
- Mechanism of Action Glutamate carboxypeptidase II inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Diabetic neuropathies; Neurodegenerative disorders; Neuropathic pain
Most Recent Events
- 16 Feb 2006 No development reported - Preclinical for Diabetic neuropathies in USA (unspecified route)
- 16 Feb 2006 No development reported - Preclinical for Neurodegenerative disorders in USA (unspecified route)
- 16 Feb 2006 No development reported - Preclinical for Neuropathic pain in USA (unspecified route)